|
|
||
| Congress | Link | Title and Authors |
|
|
||
| 2013 |  |
SLC Post-Congress Interview: Prof Michael Oellerich Written Interview performed by Eberhard Wieland with Prof. Michael Oellerich immediately after the 13th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology 2013. September 22-26, 2013. Salt Lake City, USA. |
|
|
||
| 2013 | |
SLC Pre-Congress Interview: Prof. Philip Patsalos, Dr. David Berry Written Interview performed by Eberhard Wieland with Prof. Philip Patsalos and Dr. Dave Berry about the pre-congress symposium entitled “100 Years of Antiepileptic Drugs: The role of TDM in Optimizing Patient Care”, at the 13th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology 2013. September 22-26, 2013. Salt Lake City, USA. Both interviewees answered independently and were not able to coordinate their responses. |
|
|
||
| 2013 |  |
“Bio-Nano-Chip” Technologies for Point of Care Testing of Drugs and Metabolites John T. McDevitt, Ph.D. Monday, September 23, 0915-1015 |
|
|
||
| 2013 | |
Pharmacogenomics and Personalized Cancer Treatment William E. Evans, Pharm.D. Tuesday, September 24, 0930-1030 |
|
|
||
| 2013 | |
Human Genomics a Decade after the Human Genome Project: Opportunities and Challenges Eric D. Green, M.D., Ph.D. Wednesday, September 25, 0915-1015 |
|
|
||
| 2013 | |
The Science Needed to Run an Olympic Laboratory – the Experiences of the London 2012 Olympic and Paralympic Games David Cowan BPharm, PhD, FRPharmS Thursday, September 26, 0915-1015 |
|
|
||
IATDMCT, 4 Cataraqui Street Suite 310
Kingston, ON, K7K 1Z7, Canada
